AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist

7.140
+0.060+0.85%

20min DelayMarket Closed Nov 15 16:00 AET

2.29BMarket Cap-46064P/E (Static)

Clarity Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

Operating cash flow (direct method)

Cash income from operating activities

47.94%9.95M

106.17%6.73M

3.26M

Other cash income from operating activities

47.94%9.95M

106.17%6.73M

--3.26M

Cash paid

-54.62%-55.2M

-114.63%-35.7M

-16.63M

Payments to suppliers for goods and services

-54.62%-55.2M

-114.63%-35.7M

---16.63M

Direct interest received

32.62%2.1M

1,989.39%1.58M

--75.62K

Direct tax refund paid

21.52%-80.99K

-485.30%-103.2K

---17.63K

Operating cash flow

-57.23%-43.24M

-106.55%-27.5M

---13.31M

Investing cash flow

Cash flow from continuing investing activities

-1,855.24%-55.31M

111.80%3.15M

-26.71M

Net PPE purchase and sale

-982.44%-504.01K

78.16%-46.56K

---213.15K

Net investment purchase and sale

-1,813.92%-54.8M

112.07%3.2M

---26.5M

Cash from discontinued investing activities

Investing cash flow

-1,855.24%-55.31M

111.80%3.15M

---26.71M

Financing cash flow

Cash flow from continuing financing activities

49,649.97%115.21M

-99.73%231.58K

86.93M

Net common stock issuance

67,428.20%115.19M

-99.80%170.59K

--86.8M

Net other financing activities

-67.21%20K

-53.79%61K

--132K

Cash from discontinued financing activities

Financing cash flow

49,649.97%115.21M

-99.73%231.58K

--86.93M

Net cash flow

Beginning cash position

-43.59%31.21M

555.72%55.34M

--8.44M

Current changes in cash

169.11%16.67M

-151.42%-24.12M

--46.9M

Effect of exchange rate changes

432.85%19.56K

-85.92%-5.88K

---3.16K

End cash Position

53.46%47.9M

-43.59%31.21M

--55.34M

Free cash from

-58.79%-43.74M

-103.64%-27.55M

---13.53M

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities	47.94%9.95M	106.17%6.73M	3.26M
Other cash income from operating activities	47.94%9.95M	106.17%6.73M	--3.26M
Cash paid	-54.62%-55.2M	-114.63%-35.7M	-16.63M
Payments to suppliers for goods and services	-54.62%-55.2M	-114.63%-35.7M	---16.63M
Direct interest received	32.62%2.1M	1,989.39%1.58M	--75.62K
Direct tax refund paid	21.52%-80.99K	-485.30%-103.2K	---17.63K
Operating cash flow	-57.23%-43.24M	-106.55%-27.5M	---13.31M
Investing cash flow
Cash flow from continuing investing activities	-1,855.24%-55.31M	111.80%3.15M	-26.71M
Net PPE purchase and sale	-982.44%-504.01K	78.16%-46.56K	---213.15K
Net investment purchase and sale	-1,813.92%-54.8M	112.07%3.2M	---26.5M
Cash from discontinued investing activities
Investing cash flow	-1,855.24%-55.31M	111.80%3.15M	---26.71M
Financing cash flow
Cash flow from continuing financing activities	49,649.97%115.21M	-99.73%231.58K	86.93M
Net common stock issuance	67,428.20%115.19M	-99.80%170.59K	--86.8M
Net other financing activities	-67.21%20K	-53.79%61K	--132K
Cash from discontinued financing activities
Financing cash flow	49,649.97%115.21M	-99.73%231.58K	--86.93M
Net cash flow
Beginning cash position	-43.59%31.21M	555.72%55.34M	--8.44M
Current changes in cash	169.11%16.67M	-151.42%-24.12M	--46.9M
Effect of exchange rate changes	432.85%19.56K	-85.92%-5.88K	---3.16K
End cash Position	53.46%47.9M	-43.59%31.21M	--55.34M
Free cash from	-58.79%-43.74M	-103.64%-27.55M	---13.53M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall

No Data